Raymond James & Associates’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-41,068
| Closed | -$2.12M | – | 3957 |
|
|
2022
Q3 | $2.12M | Sell |
41,068
-242,552
| -86% | -$12.5M | ﹤0.01% | 1923 |
|
|
2022
Q2 | $7.03M | Sell |
283,620
-11,213
| -4% | -$278K | 0.01% | 1179 |
|
|
2022
Q1 | $7.39M | Buy |
294,833
+16,995
| +6% | +$426K | 0.01% | 1240 |
|
|
2021
Q4 | $10.1M | Sell |
277,838
-77,352
| -22% | -$2.82M | 0.01% | 1103 |
|
|
2021
Q3 | $6.07M | Buy |
355,190
+4,904
| +1% | +$83.9K | 0.01% | 1375 |
|
|
2021
Q2 | $4.69M | Buy |
350,286
+82,679
| +31% | +$1.11M | ﹤0.01% | 1530 |
|
|
2021
Q1 | $13.7M | Buy |
267,607
+39,204
| +17% | +$2.01M | 0.01% | 855 |
|
|
2020
Q4 | $14.1M | Buy |
228,403
+146,524
| +179% | +$9.07M | 0.02% | 771 |
|
|
2020
Q3 | $4.49M | Buy |
81,879
+18,242
| +29% | +$1,000K | 0.01% | 1288 |
|
|
2020
Q2 | $3.66M | Buy |
63,637
+6,634
| +12% | +$382K | ﹤0.01% | 1376 |
|
|
2020
Q1 | $2.29M | Buy |
57,003
+25,989
| +84% | +$1.04M | ﹤0.01% | 1491 |
|
|
2019
Q4 | $1.23M | Buy |
31,014
+11,247
| +57% | +$445K | ﹤0.01% | 2147 |
|
|
2019
Q3 | $134K | Buy |
19,767
+4,943
| +33% | +$33.5K | ﹤0.01% | 3325 |
|
|
2019
Q2 | $138K | Buy |
14,824
+950
| +7% | +$8.84K | ﹤0.01% | 3321 |
|
|
2019
Q1 | $193K | Buy |
13,874
+1,700
| +14% | +$23.6K | ﹤0.01% | 3225 |
|
|
2018
Q4 | $133K | Buy |
+12,174
| New | +$133K | ﹤0.01% | 3234 |
|